4.5 Article

Inhalable Curcumin: Offering the Potential for Translation to Imaging and Treatment of Alzheimer's Disease

期刊

JOURNAL OF ALZHEIMERS DISEASE
卷 44, 期 1, 页码 283-295

出版社

IOS PRESS
DOI: 10.3233/JAD-140798

关键词

Aerosol; Alzheimer's disease; amyloid imaging; amyloid plaques; atomization; inhalation exposure; clinical translation; curcumin

资金

  1. National Institutes of Health [R01CA16700, T32 EB014841]
  2. VICC Cancer Center Support grant
  3. Grants-in-Aid for Scientific Research [26290022, 26670554] Funding Source: KAKEN
  4. NATIONAL CANCER INSTITUTE [R01CA160700] Funding Source: NIH RePORTER
  5. NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB014841] Funding Source: NIH RePORTER
  6. NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER

向作者/读者索取更多资源

Curcumin is a promising compound that can be used as a theranostic agent to aid research in Alzheimer's disease. Beyond its ability to bind to amyloid plaques, the compound can also cross the blood-brain barrier. Presently, curcumin can be applied only to animal models, as the formulation needed for iv injection renders it unfit for human use. Here, we describe a novel technique to aerosolize a curcumin derivative, FMeC1, and facilitate its safe delivery to the brain. Aside from the translational applicability of this approach, a study in the 5XFAD mouse model suggested that inhalation exposure to an aerosolized FMeC1 modestly improved the distribution of the compound in the brain. Additionally, immunohistochemistry data confirms that following aerosol delivery, FMeC1 binds amyloid plaques expressed in the hippocampal areas and cortex.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据